-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OiktJgTc36ofnX5D/T9V2M8XppuizTt0R0Z3X3Gz9beZ1MGW2nN6SOiKfVQqMJw1 gkspVtZMszIgJGURoUoINw== 0001104659-06-062371.txt : 20060921 0001104659-06-062371.hdr.sgml : 20060921 20060921160929 ACCESSION NUMBER: 0001104659-06-062371 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20060920 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060921 DATE AS OF CHANGE: 20060921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 061102334 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 8-K 1 a06-19932_28k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report:  September 20, 2006
(Date of earliest event reported)

INCYTE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

 

0-27488

 

94-3136539

(State or Other Jurisdiction of

Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer

Identification No.)

 

Experimental Station, Route 141

 

 

& Henry Clay Road, Building E336

 

 

Wilmington, DE

 

19880

(Address of principal executive offices)

 

(Zip Code)

 

(302) 498-6700

(Registrant’s telephone number,
including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 

 




Item 8.01               Other Events.

On September 20, 2006, Incyte Corporation issued a press release announcing its private offering of 3½% Convertible Senior Notes due 2011.

Item 9.01               Financial Statements and Exhibits.

(d)         Exhibits.

99.1       Press release issued by Incyte Corporation dated September 20, 2006.

2




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  September 21, 2006

 

INCYTE CORPORATION

 

 

 

 

 

 

 

 

 

 

 

By:

 

/s/ Patricia A. Schreck

 

 

 

 

 

Patricia A. Schreck

 

 

 

 

 

Executive Vice President and General Counsel

 

 

3



EX-99.1 2 a06-19932_2ex99d1.htm EX-99

Exhibit 99.1

FOR IMMEDIATE RELEASE

Pamela M. Murphy, 302-498-6944

David C. Hastings, 302-498-6883

Incyte Announces Offering of Convertible Senior Notes

Net proceeds to be used to redeem its outstanding 5.5%
 Convertible Subordinated Notes due February 1, 2007

Wilmington, DE — September 20, 2006 — Incyte Corporation (Nasdaq:INCY) today announced the offering of approximately $132 million aggregate principal amount of 3 ½% Convertible Senior Notes due 2011 in a private placement pursuant to exemptions from the registration requirements of the Securities Act of 1933.  Incyte intends to use the net proceeds of this offering, estimated to be at least $96 million (after deducting fees and expenses), to redeem its outstanding 5.5% Convertible Subordinated Notes due February 1, 2007.  A notice of redemption will be sent to the holders of those notes on or about the date of closing of the offering.  Any remaining proceeds will be added to Incyte’s working capital and will be used for general corporate purposes.

The offering is expected to close on September 26, 2006, subject to customary closing conditions.  Incyte has granted the initial purchaser of the notes an option to purchase up to an additional 15% of the aggregate principal amount of the notes.

The notes will be convertible into shares of Incyte common stock at an initial conversion rate of 89.1385 shares per $1,000 principal amount of notes, equivalent to an initial conversion price of approximately $11.22 per share.  The notes will be senior in right of payment to Incyte’s outstanding 3 ½% Convertible Subordinated Notes due 2011.  The notes will rank equal in right of payment to any future unsubordinated, unsecured debt issued by Incyte.  Incyte may redeem the notes beginning February 20, 2007.  The notes will be issued at a discount to par and will accrue original issue discount for tax purposes.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.  The notes and the common stock issuable upon conversion of the notes have not been registered under the Securities Act of 1933 or applicable state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.




Except for the historical information contained herein, the matters set forth in this press release, such as statements as to the expected use of net proceeds and the expected closing date of the offering, are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including general market conditions that may affect the satisfaction of customary closing conditions, Incyte’s proposed redemption of outstanding debt, developments affecting Incyte’s research and development activities, and other risks detailed from time to time in Incyte’s filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2006.  Incyte disclaims any intent or obligation to update these forward-looking statements.



GRAPHIC 3 g199322mai001.jpg GRAPHIC begin 644 g199322mai001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH MIKNL:EG8*!W)H`=14`N=_P#JHG<>N-H_6E#S]X5'_`__`*U.S`FHIJ,S?>0K M^.:CNKNWLH&GNIXX(EZO(P4#\318":BN0N?B5HBR&*PBO-2B_05'8JT@-W*/GE^Z/[J]A5RK?NZ(`HHJ MO?7D6GV,UY.3Y<*%B!U/L/<]*E*^@%#7-=&EB*VM8#>:E&.%!T6-0H'X"I:**Q&9VIZ!I6KQE;ZQA MF)_C*X8?1AS7)S:'J_@J1KW1)WNM.!S+:RZ%"5]'NAU%%%:EA6;K,A\J&V4\W$H7\*TJQ=8DV:QI2GHTA_I6E M)>\)FR`%4*!@`8%<+\/-3OK[5-=2\O)KA(9@(Q*Y8(-S=/3H*[NO.?AI_P`A M3Q'_`-=A_P"A/6M-)TI_+\P>YVD_B'1;>V^TRZK:+#NV[_.4C/IQWJM+>6>N MS:?'97,5S;&4SR-&P8$1XP#_`,"*G\*X3X9>'-)U:&_NM0LTN7BE$:+)RJ@C M)./6K?@JW33->\6"RCQ]D#+#'UZ%B!^@K25&$'))NZ_45SNM0\0:/I4@CO\` M4K:W<_P/(`?RIR:YI,EM'Y@M83-<31PQ+U>1@JC\37+W7C00>,[722;:/3Y8?.-V\@PX*G&# MT`R/>N+35K[QQ%HOA=UD0PL3?.?X@G`/X#]36[K.DZ=>_$_2M+GM8Y;1=/VF M$_=`7?M_+`K2-",&U/>S_P"'"]]CO&O[-;/[8UU"+;&?.+C9CUSTJMI_B#1] M5E:*PU*VN)%ZI'("?RKS[XD0FTNM#T2SM@+`#X]*N+-PRRV\R?,!V/2E'#Q<4V[7]`N>F:M9+J&ESVS#)9"5]F'(_ M6JGABX:?1(@QRT1,9_#I^F*U5)*`L,$CD>E9'AR/RHKM!]T3MBO'FN7$P:ZI MK]2'I43-FBBBNLU"N<\9;[>SM;]!S:S@GZ'_`.N!71U6U&RCU'3Y[.7[LR%< M^A['\ZNG+EFFQ,E@F2X@CGC.4D4,I]0:QM`\*6GA^XOIK>XFE-\^YQ)C"\D\ M8'O63X,UE[2YF\,:F?+N[5CY.[^->N!_,>Q]J[.KFI4VX]'^(+4Q/#/A:T\+ MP7$-K/-*+B0.QEQP<8XP*-)\,6VCZSJ&IPW$SR7[;I$?&U3G/''O6W14.I-W M;>X6./O/AU9OJ,E]I6I7FDRRDEQ;-\ISZ#M5R&VM_`WAN]NI[VXO""9FDN'R MSN0`%'U(%=)5#5M%L->$D\3ZI)KL6IW5C.LK10R0$?<3YL MWAL[>WT?3,)>70\J!5_Y8H!AI#Z!1T]\"M2TM8K*SAM81B.%`BCV`JY59(QV6XCF1BYJ6[S*!;)UD^\?1:L* MH10JC``P*X[V$OV;5;;F&4'& M['(!/\CVK,T'X@&WG_LCQ7$UA?Q_+YSKA)/<^GUZ5W=9^KZ%IFNV_DZE9QSJ M/NL1AE^A'(KHA5BX\E177XH5NQ=BECFC62*19$89#*<@_C3ZX,_#:XTZ1G\/ M^([RP!_Y9L=R_H1_*I5\/^/E&S_A*[?;_>,`)_E1[*F]IKYW"[.V)`&3P*YW M4O%]NES_`&;HL7]JZFW`BA/R1^[OT`_6J"^!+V^Q_;_B6_OD[PQGRD/UQ72Z M9I&GZ-;"VTZTCMX^X0V@:L9%%Y>68[G;[S5+1151BHJR!*P4444QA1 A110`4444`%%%%`!1110`4444`%%%%`!1110`4444`?_9 ` end
-----END PRIVACY-ENHANCED MESSAGE-----